Inovio Pharmaceuticals (INO) Short term Debt (2010 - 2023)
Inovio Pharmaceuticals (INO) posted Short term Debt of $16.8 million for Q4 2023, up 1.71% sequentially from $16.5 million in Q3 2023.
Inovio Pharmaceuticals (INO) Short term Debt (2010 - 2023) Analysis & Trends
Inovio Pharmaceuticals has reported Short term Debt for 14 years, with the latest figure at $16.8 million in Q4 2023.
- Quarterly Short term Debt changed N/A year-over-year to $16.8 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $16.8 million (changed N/A YoY) and the FY2023 annual result came in at $16.8 million, changed N/A from the prior year.
- Short term Debt advanced to $16.8 million in Q4 2023 per INO's latest filing, from $16.5 million in the prior quarter.
- Over five years, Short term Debt peaked at $16.8 million in Q4 2023 and troughed at $263456.0 in Q1 2020.
- A 5-year average of $4.2 million and a median of $794928.0 in 2020 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2020 and 2023: Short term Debt plunged 79.97% in 2020, then jumped 1148.11% in 2023.
- Over 5 years, Short term Debt stood at $729729.0 in 2019, then declined by 11.89% to $642969.0 in 2020, then declined by 14.77% to $548032.0 in 2021, then surged by 198.12% to $1.6 million in 2022, then soared by 926.49% to $16.8 million in 2023.
- According to Business Quant data, Short term Debt over the past three periods registered $16.8 million, $16.5 million, and $16.7 million for Q4 2023, Q3 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Inovio Pharmaceuticals | 96.32 Mn | 96.32 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 16.77 Mn |
| Sep 30, 2023 | 16.49 Mn |
| Jun 30, 2023 | 16.71 Mn |
| Mar 31, 2023 | 16.39 Mn |
| Sep 30, 2022 | 1.63 Mn |
| Jun 30, 2022 | 1.34 Mn |
| Mar 31, 2022 | 1.41 Mn |
| Dec 31, 2021 | 548,032.00 |
| Sep 30, 2021 | 491,645.00 |
| Jun 30, 2021 | 1.77 Mn |
| Mar 31, 2021 | 768,261.00 |
| Dec 31, 2020 | 642,969.00 |
| Sep 30, 2020 | 794,928.00 |
| Jun 30, 2020 | 511,953.00 |
| Mar 31, 2020 | 263,456.00 |
| Dec 31, 2019 | 729,729.00 |
| Sep 30, 2019 | 462,596.00 |
| Jun 30, 2019 | 653,568.00 |
| Mar 31, 2019 | 1.32 Mn |
| Dec 31, 2018 | 977,792.00 |